X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated)
BSE CODE: 500676   |   NSE CODE: NA   |   ISIN CODE : INE264A01014   |   15-Apr-2020 Hrs IST
BSE NSE
Rs. 10753.65
0 ( 0% )
 
Prev Close ( Rs.)
10753.65
Open ( Rs.)
10500.00
 
High ( Rs.)
10845.75
Low ( Rs.)
10394.05
 
Volume
2533
Week Avg.Volume
1213
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
92964
 
52 WK High-Low Range(Rs.)
Particulars Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Operational & Financial Ratios          
   Earnings Per Share (Rs)233.69  166.47  156.15  163.42  138.77  
   CEPS(Rs)248.08  181.78  171.41  177.08  153.53  
   DPS(Rs)105.00  75.00  70.00  70.00  55.00  
   Book NAV/Share(Rs)973.65  828.70  742.51  665.48  502.44  
   Tax Rate(%)35.01  34.84  35.01  34.91  34.36  
Margin Ratios          
   Core EBITDA Margin(%)23.86  20.18  18.94  18.36  16.11  
   EBIT Margin(%)31.64  24.59  22.89  23.18  19.64  
   Pre Tax Margin(%)31.62  24.55  22.83  23.13  19.62  
   PAT Margin (%)20.55  15.99  14.84  15.06  12.88  
   Cash Profit Margin (%)21.82  17.47  16.29  16.32  14.25  
Performance Ratios          
   ROA(%)11.32  9.03  9.38  11.15  11.04  
   ROE(%)25.93  21.19  22.18  27.99  29.73  
   ROCE(%)39.92  32.54  34.10  42.98  45.33  
   Asset Turnover(x)0.55  0.56  0.63  0.74  0.86  
   Sales/Fixed Asset(x)7.10  6.84  7.38  5.60  4.73  
   Working Capital/Sales(x)1.38  1.55  1.74  1.98  2.80  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.14  0.15  0.14  0.18  0.21  
   Receivable days25.36  25.01  27.84  26.69  24.68  
   Inventory Days33.39  36.30  38.05  37.10  35.19  
   Payable days311.14  291.56  287.70  264.41  221.35  
Valuation Parameters          
   PER(x)30.86  36.61  33.04  36.93  45.40  
   PCE(x)29.07  33.53  30.10  34.08  41.03  
   Price/Book(x)7.41  7.36  6.95  9.07  12.54  
   Yield(%)1.46  1.23  1.36  1.16  0.87  
   EV/Net Sales(x)5.49  5.11  4.67  5.48  5.62  
   EV/Core EBITDA(x)16.67  19.33  17.28  20.33  25.42  
   EV/EBIT(x)17.34  20.48  18.38  21.43  27.19  
   EV/CE(x)2.83  2.72  2.51  3.44  4.21  
   M Cap / Sales6.34  5.94  5.44  6.14  6.15  
Growth Ratio          
   Net Sales Growth(%)10.78  8.15  -3.51  -3.98  -11.52  
   Core EBITDA Growth(%)37.94  5.88  -3.43  17.20  -11.83  
   EBIT Growth(%)40.57  6.24  -4.26  18.92  -12.51  
   PAT Growth(%)40.38  6.61  -4.45  17.77  -13.51  
   EPS Growth(%)40.38  6.61  -4.45  17.77  -13.51  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)2.47  2.62  2.59  2.58  1.96  
   Quick Ratio(x)2.27  2.39  2.31  2.26  1.68  
   Interest Cover(x)1943.07  530.19  364.69  464.16  1201.09  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00